Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eliapixant (BAY 1817080) (BAY 1817080) is a potent and selective P2X3 receptor antagonist, with an IC50 of 8 nM. Eliapixant can be used for the research of refractory chronic cough.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 135.00 | |
5 mg | In stock | $ 289.00 | |
10 mg | In stock | $ 463.00 | |
25 mg | In stock | $ 763.00 | |
50 mg | In stock | $ 1,070.00 | |
100 mg | In stock | $ 1,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 297.00 |
Description | Eliapixant (BAY 1817080) (BAY 1817080) is a potent and selective P2X3 receptor antagonist, with an IC50 of 8 nM. Eliapixant can be used for the research of refractory chronic cough. |
Targets&IC50 | P2X3:8 nM |
In vivo | Eliapixant can be used in the study of coughs and diabetes complications[1]. |
Synonyms | BAY 1817080 |
Molecular Weight | 478.49 |
Formula | C22H21F3N4O3S |
CAS No. | 1948229-21-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30mg/mL (62.70mM), ultrasonic and warming and heat to 60℃
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eliapixant 1948229-21-7 Membrane transporter/Ion channel Neuroscience P2X Receptor Inhibitor chronic cough refractory BAY 1817080 BAY1817080 P2X3 BAY-1817080 inhibit P2XRs inhibitor